Stockreport

Milestone Pharmaceuticals: Playing The Long Ball In Cardiovascular Treatment [Seeking Alpha]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF The firm faced setbacks this year with FDA CMC concerns and shareholder dilution, but now has sufficient cash to reach approval and its $75 million royalty milestone. [Read more]